UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (35), p.13051-13056

2008

Volltextzugriff (PDF)

An efficient alternative to the stratified Cox model analysis

Statistics in medicine, 2012-07, Vol.31 (17), p.1849-1856

2012

Volltextzugriff (PDF)

A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL)

Human vaccines & immunotherapeutics, 2018-12, Vol.14 (12), p.2916-2920

2018

Volltextzugriff (PDF)

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The Pediatric infectious disease journal, 2020-08, Vol.39 (8), p.763-770

2020

Volltextzugriff (PDF)

Population-Enrichment Adaptive Design Strategy for an Event-Driven Vaccine Efficacy Trial

Statistics in biosciences, 2018-08, Vol.10 (2), p.357-370

2018

Volltextzugriff (PDF)

Long-term Persistence of Zoster Vaccine Efficacy

Clinical infectious diseases, 2015-03, Vol.60 (6), p.900-909

2015

Volltextzugriff (PDF)

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50—59 Years

Clinical infectious diseases, 2012-04, Vol.54 (7), p.922-928

2012

Volltextzugriff (PDF)

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

The Journal of infectious diseases, 2014-11, Vol.210 (10), p.1573-1581

2014

Volltextzugriff (PDF)

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults

The Journal of infectious diseases, 2016-01, Vol.213 (1), p.14-22

2016

Volltextzugriff (PDF)

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2018-05, Vol.391 (10135), p.2116-2127

2018

Volltextzugriff (PDF)

Spatial Analyses Identify the Geographic Source of Patients at a National Cancer Institute Comprehensive Cancer Center

Clinical cancer research, 2010-02, Vol.16 (3), p.1065-1072

2010

Volltextzugriff (PDF)

Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old

Human vaccines, 2010-11, Vol.6 (11), p.894-902

2010

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids

Vaccine, 2015-06, Vol.33 (27), p.3129-3134

2015

Volltextzugriff (PDF)

Modified test statistics by inter-voxel variance shrinkage with an application to f MRI

Biostatistics (Oxford, England), 2009-04, Vol.10 (2), p.219-227

2009

Volltextzugriff (PDF)

Varicella-Zoster Virus–Specific Antibody Responses in 50-59-Year-Old Recipients of Zoster Vaccine

The Journal of infectious diseases, 2013-11, Vol.208 (9), p.1386-1390

2013

Volltextzugriff (PDF)

Reply to Dunning

The Journal of infectious diseases, 2015-11, Vol.212 (9), p.1521-1523

2015

Volltextzugriff (PDF)

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

Open forum infectious diseases, 2020-07, Vol.7 (7), p.ofaa172-ofaa172

2020

Volltextzugriff (PDF)

County-Level Basics of Living Affects Overall Mortality Rate in the United States – 2000

Applied Research in Quality of Life, 2006-05, Vol.1 (1), p.97-106

2006

Volltextzugriff (PDF)

Abstract CT042: Pembrolizumab 400 mg Q6W dosing: First clinical outcomes data from Keynote-555 cohort B in metastatic melanoma patients

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT042-CT042

2020

Volltextzugriff (PDF)

KEYNOTE-119: A randomized phase III study of single-agent pembrolizumab (MK-3475) vs single-agent chemotherapy per physician's choice for metastatic triple-negative breast cancer (mTNBC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.TPS1102-TPS1102

2016

Volltextzugriff (PDF)

Abstract CT283: KEYNOTE-966: A randomized, double-blind, placebo-controlled, phase 3 study of pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT283-CT283

2020

Volltextzugriff (PDF)

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

The Lancet infectious diseases, 2019-09, Vol.19 (9), p.1001-1012

2019

Volltextzugriff (PDF)

County lung cancer mortality: a decision tree model for control and prevention

Journal of public health management and practice, 2008-07, Vol.14 (4), p.E1-E9

2008

Volltextzugriff (PDF)

6 - A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts)

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S24-S25

2017

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(28)
Humans
(25)
Female
(18)
Male
(18)
Middle Aged
(14)
Herpes Zoster
(10)
Immunology
(10)
Aged
(9)
Biological And Medical Sciences
(9)
Herpes Zoster - Prevention & Control
(9)
Medical Sciences
(9)
Adult
(8)
Herpes Zoster Vaccine - Immunology
(8)
Infectious Diseases
(8)
Physical Sciences
(8)
Vaccines
(8)
Chemistry
(7)
Safety
(7)
Antibodies, Viral - Blood
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

An efficient alternative to the stratified Cox model analysis

A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL)

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Population-Enrichment Adaptive Design Strategy for an Event-Driven Vaccine Efficacy Trial

Long-term Persistence of Zoster Vaccine Efficacy

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50—59 Years

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

Spatial Analyses Identify the Geographic Source of Patients at a National Cancer Institute Comprehensive Cancer Center

Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old

Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids

Modified test statistics by inter-voxel variance shrinkage with an application to f MRI

Varicella-Zoster Virus–Specific Antibody Responses in 50-59-Year-Old Recipients of Zoster Vaccine

Reply to Dunning

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

County-Level Basics of Living Affects Overall Mortality Rate in the United States – 2000

Abstract CT042: Pembrolizumab 400 mg Q6W dosing: First clinical outcomes data from Keynote-555 cohort B in metastatic melanoma patients

KEYNOTE-119: A randomized phase III study of single-agent pembrolizumab (MK-3475) vs single-agent chemotherapy per physician's choice for metastatic triple-negative breast cancer (mTNBC)

Abstract CT283: KEYNOTE-966: A randomized, double-blind, placebo-controlled, phase 3 study of pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract carcinoma

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

County lung cancer mortality: a decision tree model for control and prevention

6 - A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts)

Suchergebnisse filtern